Adolphe Gubler and the Journal de Thérapeutique (1874-1883)
DOI:
https://doi.org/10.3989/asclepio.1993.v45.2.490Abstract
The present piece of work intends to approach one of the French journals on therapeutics that most influenced the Spanish medicine of the 19th century, i.e. the Journal de thérapeutique. Despite its relatively short editorial life, from 1874 to 1883, it indeed was published during one of the most important periods in the history of therapeutics and pharmacology in Europe, and served, so to speak, as a binding bridge between the clinical reality of the time and the new and revolutionary achievements in experimental pharmacology quite successfully personalized by François Magendie. The life and soul of the publication was Adolphe Gubler who significantly influenced on the Spanish physicians of the last quarter of the 19th century. The present work first lingers on the foundations that inspired Gubler's thought that may as well apply to what made the pith of the editorial line of the journal; it goes on to make a description of the formal aspects of the review and of its main section devoted to Its original works. The survey ends up by including a list of them and a subject index.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Consejo Superior de Investigaciones Científicas (CSIC)

This work is licensed under a Creative Commons Attribution 4.0 International License.
© CSIC. Manuscripts published in both the print and online versions of this journal are the property of the Consejo Superior de Investigaciones Científicas, and quoting this source is a requirement for any partial or full reproduction.
All contents of this electronic edition, except where otherwise noted, are distributed under a Creative Commons Attribution 4.0 International (CC BY 4.0) licence. You may read the basic information and the legal text of the licence. The indication of the CC BY 4.0 licence must be expressly stated in this way when necessary.
Self-archiving in repositories, personal webpages or similar, of any version other than the final version of the work produced by the publisher, is not allowed.